Intra-Cellular Therapies Inc. buy Needham & Company LLC
Start price
07.05.24
/
50%
€64.00
Target price
07.05.25
€83.49
Performance (%)
16.41%
Price
26.07.24
€74.50
Summary
This prediction is currently active. The prediction currently has a performance of 16.41%. This prediction currently runs until 07.05.25. The prediction end date can be changed by Needham___Company_LL at any time. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Intra-Cellular Therapies Inc. | 7.971% | 7.971% |
iShares Core DAX® | 1.280% | 1.027% |
iShares Nasdaq 100 | -2.457% | -4.650% |
iShares Nikkei 225® | -2.006% | -2.091% |
iShares S&P 500 | -0.662% | -1.246% |
Comments by Needham___Company_LL for this prediction
In the thread Intra-Cellular Therapies Inc. diskutieren
Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $90.00 price target on the stock.
Ratings data for ITCI provided by MarketBeat
Stopped prediction by Needham___Company_LL for Intra-Cellular Therapies Inc.
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€69.50
22.07.24
22.07.24
€91.90
22.07.25
22.07.25
7.19%
26.07.24
26.07.24
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€71.00
18.06.24
18.06.24
€87.54
18.06.25
18.06.25
4.93%
26.07.24
26.07.24
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€70.50
22.04.24
22.04.24
€84.46
22.04.25
22.04.25
5.67%
26.07.24
26.07.24
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€64.00
05.04.24
05.04.24
€75.83
05.04.25
05.04.25
16.41%
26.07.24
26.07.24
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€63.50
23.02.24
23.02.24
€75.68
23.02.25
23.02.25
17.32%
26.07.24
26.07.24
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€53.70
03.08.23
03.08.23
€66.63
03.08.24
03.08.24
36.87%
26.07.24
26.07.24
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€56.40
20.04.23
20.04.23
€60.11
20.04.24
20.04.24
22.34%
21.04.24
21.04.24
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€52.40
29.03.23
29.03.23
€60.85
29.03.24
29.03.24
22.14%
30.03.24
30.03.24